high-throughput screening assays (Tularik Inc)
90
Structured Review
Tularik Inc
high-throughput screening assays
High Throughput Screening Assays, supplied by Tularik Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/throughput+screening/high+throughput+screening+method/us07838230-21-8-8
Average 90 stars, based on 1 article reviews
High Throughput Screening Assays, supplied by Tularik Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/throughput+screening/high+throughput+screening+method/us07838230-21-8-8
Average 90 stars, based on 1 article reviews
high-throughput screening assays - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: employment Article Snippet: As a result of the continued growth of our Combinatorial and Parallel Synthesis (C&PS) group, we have a number of exciting I m applying their synthetic skills to c As a member of a multiéisàpiinary teamr you will take medicinal chemistry, high-throughput screening (HTS), « crystallography and àeminformatics to design and synthesize of our expertise in 1, x-ray Scientists Combinatorial Chemistry You will participate in the early-stage optimization of chemical leads from Article Title: employment Article Snippet: The successful candidate will collaborate with scientists from other departments in order to optimize chemical leads identified using Article Title: Assay for measuring an enzyme's capability to modify supercoil topology of nucleic acids and modulators Article Snippet: Accordingly, this is a drawback for the known Article Title: Sugen's European strategy Article Snippet: In April, Sugen (S. San Francisco, CA) established a European subsidiary, Sugen Europe (Schaffhausen, Switzerland), which aims to partner with several small, local pharmaceutical firms in order to distribute its portfolio of cancer products across the continent.. According to CEO Stephen Evans-Freke, this strategy will give Sugen Europe a greater share of the European oncology market than could be achieved via one major international pharmaceutical firm.. He notes that the three largest European oncology distributors—AstraZeneca (London), Bristol Myers Squibb (New York), and Pharmacia & Upjohn (San Diego, CA)— each hold only 15% of the market; EvansFreke hopes to beat this. Activation Assay:Article Title: Modulation of Th1 and Th2 responses for immunotherapy Article Snippet: Novel therapeutic agents that differentially modulate immune responses are needed to boost protective immunity against infections and neoplasms and conversely, to suppress inappropriate immune reactions responsible for allergic and autoimmune disorders and the rejection of transplanted organs.. One major concept that has guided the search for such agents asserts the existence of at least two types of CD4+ helper T-cells, Th1 and Th2 cells, that differ in their pattern of cytokine production and govern different arms of the immune response.. Th1 cells produce IFN-γ, IL-2 and TNF-β and are involved in cell-mediated immune responses that are beneficial in host-defence against intracellular pathogens and malignant cells, but detrimental in mediating autoimmunity. Binding Assay:Article Title: Modulation of Th1 and Th2 responses for immunotherapy Article Snippet: Novel therapeutic agents that differentially modulate immune responses are needed to boost protective immunity against infections and neoplasms and conversely, to suppress inappropriate immune reactions responsible for allergic and autoimmune disorders and the rejection of transplanted organs.. One major concept that has guided the search for such agents asserts the existence of at least two types of CD4+ helper T-cells, Th1 and Th2 cells, that differ in their pattern of cytokine production and govern different arms of the immune response.. Th1 cells produce IFN-γ, IL-2 and TNF-β and are involved in cell-mediated immune responses that are beneficial in host-defence against intracellular pathogens and malignant cells, but detrimental in mediating autoimmunity. |